I for one welcome my immortal transhumanist cyborg overlords. But seriously, the fact that the first thing they do is start a corporation to control the science is not exactly comforting to me. Genentech is known for selling Avastin, their drug that fights cancer for $55k after they received harsh criticism for the proposed cost of $100k+/year. http://en.wikipedia.org/wiki/Bevacizumab#Costs I fear a future where "all…
Like with anything else, the question isn't whether the rich will be able to afford it, the question is how much progress can we make in making it cheap, how quickly, to get it to how many people? It is a moral imperative to make sure that short-sighted class warfare does not cut off the nose to spite the face by destroying this work under the guise of egalitarianism, because we can not turn on a dime and immediately…
Your argument hinges on a hoary anti-Marxist critique. As one example alternative approach, the hundreds of billions, if not trillions, of dollars handed out to financial institutions and/or forgiven in legal penalties could have been used to reimburse companies for creating successful health technologies and treatments. It's a matter of policies and priorities, some of which are broken and some that aren't (Sturgeon's Law), and the market structures of medicine operate in the way that it does for specific reasons not necessarily aligned with benefits for those who are dying or sick.
tl;dr: TIMTOWTDI